Market Place
Sourcing Support
The Biopharmaceutical Cartel And High Drug Prices
10 Apr 2019 //
FORBES
Medicare Part D no match for runaway specialty drug costs: study
07 Feb 2019 //
REUTERS
Merck runs out of Parkinson’s disease drug Sinemet as manufacturing issues
04 Oct 2018 //
FIERCE PHARMA
Merck Is Lowering Drug Prices. There’s a Catch
20 Jul 2018 //
THE HILL
Merck write-downs $1.9bn as market shrinks
24 Feb 2017 //
THE PENINSULAR QATAR
Merck takes US$1.9b writedown as hepatitis C market shrinks
23 Feb 2017 //
BUSINESS TIMES
Merck falls short in Q4 sales but sees EPS growth ahead
02 Feb 2017 //
FIERCE PHARMA
Two new hepatitis C therapies fast-tracked in Europe
25 Jan 2017 //
PMLIVE
SMC OKs four new therapies for NHS use in Scotland
18 Jan 2017 //
PHARMATIMES
AbbVie`s pan-genotypic hep C prospect shines in trials
14 Nov 2016 //
FIERCE PHARMA
Recent Success in HCV Treatment Brings Relief to Patients
07 Nov 2016 //
DRUG DEVELOPMENT
NICE nods for Tagrisso, Cimzia and Zepatier
27 Oct 2016 //
PHARMATIMES
Study Stopped as Merck & Co. Immunotherapy Drug Wows in Bladder Cancer Trial
22 Oct 2016 //
BIOSPACE
NICE green light for Merck’s hepatitis C drug Zepatier
10 Sep 2016 //
PHARMATIMES
FDA Calls for Head-to-Head Trials in Revised Draft Guidance on Hepatitis C
03 May 2016 //
RAPS
Merck says its Zepatier showed better efficacy, safety compared with competition
13 Apr 2016 //
PHARMAFILE
Drug Spending Slowed in 2015 After Discounts, CVS Health Says
24 Feb 2016 //
BLOOMBERG
Gilead nabs two new Harvoni approvals as hep C contest heats up
17 Feb 2016 //
FIERCE PHARMA
Diplomat to Dispense ZEPATIER™ to Treat Patients with Chronic Hepatitis C Virus
16 Feb 2016 //
PR NEWSWIRE
The top 10 (possible) blockbusters that (might) launch this year
28 Jan 2016 //
FIERCE BIOTECH
Merck & Co posts positive hepatitis C data
18 Nov 2015 //
PM LIVE
Merck drug could offer Hep C cure to kidney disease patients
06 Oct 2015 //
PHARMATIMES
US FDA accepts for review Merck`s NDA for grazoprevir/elbasvir to treat chronic hepatitis C
30 Jul 2015 //
PHARMABIZ
Merck Targets Toughest Cases to Gain Hepatitis C Foothold
28 Jul 2015 //
BLOOMBERG BUSINESS
Hep C landscape shifts again as BMS combo nabs breakthrough tag
20 May 2015 //
FIERCE PHARMA
Will AbbVie (ABBV)`s HCV Candidates Threaten Gilead (GILD)?
09 Apr 2015 //
BIOSPACE
FDA Stamps Merck`s Hep C Drug As Breakthough Therapy
09 Apr 2015 //
BIOSPECTRUM ASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.